The Center for African Studies (CAS) is excited to partner with the Stanford African Scholars in Global Health Program (SASH) for an engaging Africa Table lecture on February 12th from 12–1 PM at 123 Encina Hall. This event will spotlight the impactful work of global scholars addressing critical health challenges in Africa.
Search
Gilead Sciences Announces Partnership with PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- & Lower-Middle-Income Countries
Gilead Sciences Read More
FHI 360 Welcomes ‘Game-Changing’ HIV Prevention Method
FHI 360 Read More
Gilead Statement on New CDC Guidelines on Twice-Yearly Yeztugo® (Lenacapavir) for HIV Prevention
Gilead Sciences Read More
NIH Ponders Overhauling HIV Budget to Capitalize on Prevention Breakthrough
Gilead Sciences Read More
Gilead Sciences Launches Choose U™ Campaign Spotlighting the Inspiring Experiences of People Living with HIV
Gilead Sciences Read More
EU Approves New Injection for Preventing HIV
Gilead Sciences Read More
Can AI Create Safe Spaces for Young Women to Learn About HIV?
Audere Read More
HIV Prevention Gets an AI Upgrade
Audere Africa, PSI Read More
Gilead Sciences and Global Fund Finalize Plan to Supply HIV Prevention Drug to Poor Countries
Gilead Sciences Read More
Closing the Gaps: Launch of a Network-Based Testing Toolkit to Expand HIV, Hepatitis, and STI Testing Reach
In this PSI webinar, WHO will introduce a new toolkit to support integrated NBT service delivery for HIV, hepatitis B and C, and other STIs, and present practical examples of how NBT can be implemented efficiently in resource-constrained settings.
The Time Has Come for Multipurpose Prevention Technologies (MPTs): Transforming STI/HIV Prevention
Join PHI’s CAMI Health/IMPT for their symposium, “The Time Has Come for Multipurpose Prevention Technologies (MPTs): Transforming STI/HIV Prevention” on Sunday, July 27 from 10:45 AM to 12:15 PM as part of the upcoming STI & HIV 2025 World Congress conference, in Montreal, Canada.
The Decades-Long Journey to the Twice-a-Year HIV Prevention Drug Lenacapavir
Gilead Sciences Read More
Report: Principles of a responsible transition of American leadership to end AIDS
Friends of the Global Fight Read More
Behavioural Insights Report: Self-Care from Anywhere
Audere Africa Read More
U.S. Global Health Funding: Breaking Down the Budget
Join the Harvard Global Health Institute for a timely conversation on the evolving landscape of U.S. global health funding. This session will provide a critical assessment of the current operating status of major programs including the President’s Emergency Plan for AIDS Relief (PEPFAR), the President’s Malaria Initiative (PMI), and the Global Fund to Fight AIDS, Tuberculosis, and Malaria.
Elimination: Maximizing the Impact of HIV Testing for Pregnant and Postpartum Women
The elimination of mother-to-child transmission of HIV (EMTCT) is a cornerstone of global efforts to achieve the triple elimination of mother-to-child transmission of HIV, syphilis, and hepatitis B. Worldwide, HIV treatment coverage among pregnant women has increased from 48% in 2010 to 82% in 2022. However, progress has stalled over the past seven years, leaving 130,000 children newly infected each year, mainly in sub-Saharan Africa. Through different country lenses, this webinar will explore cornerstones of HIV testing services delivery to achieve EMTCT, including catch-up testing, re-testing, linkage to prevention or treatment, and network-based testing.
New Report: Artificial Intelligence to Enhance HIV Prevention in Age of Disruptions
Audere Africa Read More
IAS 2025
Join IAS 2025 in Kigali or virtually from 13–16 July 2025 to explore the latest breakthroughs in HIV science. Standard registration closes 6 May 2025.
Putting HIV, TB, & Viral Hepatitis at the Heart of Climate-Resilient Health Systems
PSI Read More




















